BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 27784363)

  • 21. Total metabolic tumor volume, circulating tumor cells, cell-free DNA: distinct prognostic value in follicular lymphoma.
    Delfau-Larue MH; van der Gucht A; Dupuis J; Jais JP; Nel I; Beldi-Ferchiou A; Hamdane S; Benmaad I; Laboure G; Verret B; Haioun C; Copie-Bergman C; Berriolo-Riedinger A; Robert P; Casasnovas RO; Itti E
    Blood Adv; 2018 Apr; 2(7):807-816. PubMed ID: 29636326
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostic value of circulating cell-free DNA levels for hepatocellular carcinoma.
    Yan L; Chen Y; Zhou J; Zhao H; Zhang H; Wang G
    Int J Infect Dis; 2018 Feb; 67():92-97. PubMed ID: 29229500
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cell-free DNA levels in plasma of patients with non-small-cell lung cancer and inflammatory lung disease.
    Szpechcinski A; Chorostowska-Wynimko J; Struniawski R; Kupis W; Rudzinski P; Langfort R; Puscinska E; Bielen P; Sliwinski P; Orlowski T
    Br J Cancer; 2015 Jul; 113(3):476-83. PubMed ID: 26125447
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic and prognostic potential of circulating cell-free genomic and mitochondrial DNA fragments in clear cell renal cell carcinoma patients.
    Lu H; Busch J; Jung M; Rabenhorst S; Ralla B; Kilic E; Mergemeier S; Budach N; Fendler A; Jung K
    Clin Chim Acta; 2016 Jan; 452():109-19. PubMed ID: 26569345
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical significance of cell-free DNA as a prognostic biomarker in patients with diffuse large B-cell lymphoma.
    Eskandari M; Manoochehrabadi S; Pashaiefar H; Zaimy MA; Ahmadvand M
    Blood Res; 2019 Jun; 54(2):114-119. PubMed ID: 31309089
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The level and integrity of plasma circulating cell-free DNA in patients with primary multiple myeloma.
    Shen Q; Cen H; Jiang J; Cong Z; Zhou Y; Huang X; Zhu L; Jiang Q; Xue C
    Transl Cancer Res; 2022 Nov; 11(11):4137-4147. PubMed ID: 36523306
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circulating cell-free DNA: A potential biomarker to differentiate inflammation and infection during radiochemotherapy.
    Zwirner K; Hilke FJ; Demidov G; Ossowski S; Gani C; Rieß O; Zips D; Welz S; Schroeder C
    Radiother Oncol; 2018 Dec; 129(3):575-581. PubMed ID: 30097252
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TP53 mutations in circulating free DNA from Egyptian patients with non-Hodgkin's lymphoma.
    Hosny G; Farahat N; Hainaut P
    Cancer Lett; 2009 Mar; 275(2):234-9. PubMed ID: 19046801
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circulating free DNA in the progression of liver damage to hepatocellular carcinoma.
    Piciocchi M; Cardin R; Vitale A; Vanin V; Giacomin A; Pozzan C; Maddalo G; Cillo U; Guido M; Farinati F
    Hepatol Int; 2013 Oct; 7(4):1050-7. PubMed ID: 26202034
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma cell-free DNA in canine lymphoma patients as a novel material for genotyping.
    Kambayashi S; Ono N; Tone T; Baba K; Okuda M
    Vet Comp Oncol; 2024 Jun; 22(2):303-309. PubMed ID: 38287199
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cell-Free DNA as a Biomarker at Diagnosis and Follow-Up in 256 B and T-Cell Lymphomas.
    Diez-Feijóo R; Andrade-Campos M; Gibert J; Sánchez-González B; Fernández-Ibarrondo L; Fernández-Rodríguez C; Garcia-Gisbert N; Camacho L; Lafuente M; Vázquez I; Colomo L; Salar A; Bellosillo B
    Cancers (Basel); 2024 Jan; 16(2):. PubMed ID: 38254810
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Circulating cell-free DNA as predictor of pathological complete response in locally advanced rectal cancer patients undergoing preoperative chemoradiotherapy.
    Truelsen CG; Kronborg CS; Sørensen BS; Callesen LB; Spindler KG
    Clin Transl Radiat Oncol; 2022 Sep; 36():9-15. PubMed ID: 35733829
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of EGFR L858R Mutation in Circulating Free DNA With Survival in the EURTAC Trial.
    Karachaliou N; Mayo-de las Casas C; Queralt C; de Aguirre I; Melloni B; Cardenal F; Garcia-Gomez R; Massuti B; Sánchez JM; Porta R; Ponce-Aix S; Moran T; Carcereny E; Felip E; Bover I; Insa A; Reguart N; Isla D; Vergnenegre A; de Marinis F; Gervais R; Corre R; Paz-Ares L; Morales-Espinosa D; Viteri S; Drozdowskyj A; Jordana-Ariza N; Ramirez-Serrano JL; Molina-Vila MA; Rosell R;
    JAMA Oncol; 2015 May; 1(2):149-57. PubMed ID: 26181014
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Effect of Preservative and Temperature on the Analysis of Circulating Tumor DNA.
    Parpart-Li S; Bartlett B; Popoli M; Adleff V; Tucker L; Steinberg R; Georgiadis A; Phallen J; Brahmer J; Azad N; Browner I; Laheru D; Velculescu VE; Sausen M; Diaz LA
    Clin Cancer Res; 2017 May; 23(10):2471-2477. PubMed ID: 27827317
    [No Abstract]   [Full Text] [Related]  

  • 35. Serum cell-free DNA concentrations and integrity analysis of colorectal cancer patients before and after surgery.
    Cao G; Xie Y; Jiang X; Tian X; Wang D; Sun Y
    Cell Mol Biol (Noisy-le-grand); 2019 Jul; 65(6):44-51. PubMed ID: 31472046
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma cfDNA for the Diagnosis and Prognosis of Colorectal Cancer.
    Wu Z; Yu L; Hou J; Cui L; Huang Y; Chen Q; Sun Y; Lu W; Zhang C; Sun D
    J Oncol; 2022; 2022():9538384. PubMed ID: 35685424
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endotheliopathy is associated with higher levels of cell-free DNA following major trauma: A prospective observational study.
    Naumann DN; Hazeldine J; Dinsdale RJ; Bishop JR; Midwinter MJ; Harrison P; Hutchings SD; Lord JM
    PLoS One; 2017; 12(12):e0189870. PubMed ID: 29261771
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An improved digital polymerase chain reaction protocol to capture low-copy KRAS mutations in plasma cell-free DNA by resolving 'subsampling' issues.
    Ono Y; Sugitani A; Karasaki H; Ogata M; Nozaki R; Sasajima J; Yokochi T; Asahara S; Koizumi K; Ando K; Hironaka K; Daito T; Mizukami Y
    Mol Oncol; 2017 Oct; 11(10):1448-1458. PubMed ID: 28691390
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitative Methylation-Specific PCR: A Simple Method for Studying Epigenetic Modifications of Cell-Free DNA.
    Sigalotti L; Covre A; Colizzi F; Fratta E
    Methods Mol Biol; 2019; 1909():137-162. PubMed ID: 30580429
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serial perioperative cell-free DNA levels in donors and recipients undergoing living donor liver transplantation.
    Prakash K; Aggarwal S; Bhardwaj S; Ramakrishna G; Pandey CK
    Acta Anaesthesiol Scand; 2017 Oct; 61(9):1084-1094. PubMed ID: 28766696
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.